BerganKDV Wealth Management’s Elevance Health ELV Stock Holding History

BerganKDV Wealth Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$12.8K	Sell	29 -18	-38%	-$8.3K	﹤0.01%	534
2023 Q1	$21.6K	Sell	47 -20	-30%	-$9.52K	﹤0.01%	509
2022 Q4	$34.3K	Buy	67 +20	+43%	+$10.2K	﹤0.01%	417
2022 Q3	$21K	Sell	47 -6	-11%	-$2.87K	﹤0.01%	485
2022 Q2	$25K	Hold	53	–	–	﹤0.01%	467
2022 Q1	$26K	Hold	53	–	–	﹤0.01%	483
2021 Q4	$24K	Buy	53 +1	+2%	+$421	﹤0.01%	518
2021 Q3	$20K	Hold	52	–	–	﹤0.01%	527
2021 Q2	$20K	Hold	52	–	–	﹤0.01%	517
2021 Q1	$19K	Sell	52 -6	-10%	-$1.93K	﹤0.01%	490
2020 Q4	$19K	Buy	58 +6	+12%	+$1.84K	﹤0.01%	483
2020 Q3	$14K	Sell	52 -48	-48%	-$12.9K	﹤0.01%	466
2020 Q2	$26K	Buy	100 +37	+59%	+$9.87K	﹤0.01%	429
2020 Q1	$14K	Buy	63 +6	+11%	+$1.64K	﹤0.01%	458
2019 Q4	$17K	Buy	57 +31	+119%	+$8.53K	﹤0.01%	468
2019 Q3	$6K	Hold	26	–	–	﹤0.01%	539
2019 Q2	$7K	Hold	26	–	–	﹤0.01%	552
2019 Q1	$7K	Hold	26	–	–	﹤0.01%	564
2018 Q4	$7K	Buy	+26	New	+$7.15K	﹤0.01%	516

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BerganKDV Wealth Management's ELV Position: Q2 2023 in Review

BerganKDV Wealth Management reduced its Elevance Health (ELV) stake by 38% in Q2 2023, selling an estimated $8.3K and leaving 29 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #534.

BerganKDV Wealth Management first reported a position in ELV in Q4 2018 and has held it in 19 quarters since. The position peaked at $34.3K in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

BerganKDV Wealth Management held 29 shares of Elevance Health worth $12.8K as of Q2 2023.
BerganKDV Wealth Management sold 18 Elevance Health shares in Q2 2023, an estimated $8.3K.
Elevance Health made up ﹤0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #534 holding.
BerganKDV Wealth Management first reported a position in Elevance Health in Q4 2018 and has held it in 19 quarters since.
BerganKDV Wealth Management's Elevance Health position peaked at $34.3K in Q4 2022.
1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.